Research Faculty

William Atchison, Ph.D.
Professor *
Department of Pharmacology & Toxicology

Location: B331A Life Sciences
Phone: (517) 353-4947
Email: atchiso1@msu.edu

Fields of Interest: Research in my lab is directed at understanding the basis of cellular neurotoxicity, especially at synapses.

Andrea Doseff, Ph.D.
Professor *
Department of Physiology | Pharmacology & Toxicology

Location: 567 Wilson Rd
Phone: (517) 884-5155
Email: doseffan@msu.edu

Fields of Interest: Regulatory gene and protein networks of immune cell fate and apoptosis; anti-inflammatory and anti-carcinogenic mechanisms of phytochemicals; phytochemical target identification; the role of cell death regulators in immune-regulation and immune-oncology; foods for health.

Edmund Ellsworth, Ph.D.
Professor
Department of Pharmacology & Toxicology

Location: B347 Life Sciences
Phone: (517) 884-8816
Email: ellswo59@msu.edu

Fields of Interest:  (Coming Soon)

Jay Goodman, Ph.D.
Professor (Emeritus)
Department of Pharmacology & Toxicology

Location: 310 Food Safety and Toxicology
Phone: (517) 353-9346
Email: goodman3@msu.edu

Fields of Interest: My research interests are focused on discerning epigenetic mechanisms underlying carcinogenesis and other chemical-induced toxicities.

Colleen Hegg, Ph.D.
Associate Professor *
Department of Pharmacology & Toxicology

Location: B439 Life Sciences
Phone: (517) 432-2339
Email: hegg@msu.edu

Fields of Interest: The Hegg lab research is focused on adult neurogenesis and investigates (1) the role and mechanisms of signalling of various trophic factors and (2) the effects of environmental pollutants on neurogenesis.

Norbert E. Kaminski, Ph.D.
Professor *
Department of Pharmacology & Toxicology
Director – Institute for Integrative Toxicology
Interim Director – Center for Research on Ingredient Safety

Location: Food Safety, Rm 315

Phone: (517) 353-3786
Email: kamins11@msu.edu

Fields of Interest: Elucidation of the molecular mechanisms for impairment of signal transduction cascades and gene expression during lymphocyte activation by drugs and chemicals; mechanism for immune modulation by cannabinoid compounds

Kin Sing Stephen Lee, Ph.D.
Assistant Professor *
Department of Pharmacology & Toxicology

Location: B330A Life Sciences
Phone: (517) 884-1813
Email: sing@msu.edu

Fields of Interest:  Our research is focused on investigating the molecular mechanisms on how dietary lipids affect human health and human responses to environmental toxicants.

Keith J Lookingland, Ph.D.
Associate Professor
Department of Pharmacology & Toxicology

Location: B432 Life Sciences
Phone: (517) 353-8971
Email: lookingl@msu.edu

Fields of Interest: The goal of research in my laboratory is to develop a murine model for periodic limb movements employing neurotoxin-induced lesions of the A11 diencephalospinal dopamine neurons and remote sensing assessment of hindlimb during the awake/sleep cycle.

Yukun Yuan, B.M. (M.D.), M.M. (M.S.), Ph.D.
Associate Professor
Department of Pharmacology & Toxicology

Location: B307A Life Sciences
Phone: (517) 432-9513
Email: yuanyuku@msu.edu

Fields of Interest: (Coming Soon)


James P. Luyendyk, Ph.D.
Professor
Institute for Integrative Toxicology
Department of Pharmacology & Toxicology

Location: 253 Food Safety
Phone: (517) 884-2057
Email: luyendyk@msu.edu

Fields of Interest:The liver synthesizes numerous coagulation factors, making altered hemostasis a significant concern in patients with end-stage liver disease. Our laboratory approaches this connection early in the pathogenesis of liver disease. The team’s long-term goal is to understand the mechanisms whereby the coagulation cascade contributes to the pathogenesis of liver disease. [excerpt, Luyendyk Laboratory site]

Jack Harkema, DVM, PHD, DACVP, ATSF
University Distinguished Professor
Department of Pharmacology & Toxicology

Location: 212 Food Safety and Toxicology
Phone: (517) 353-8627
Email: harkemaj@msu.edu

Fields of Interest: To understand the pathologic basis of health effects caused by environmental and occupational air pollutants
Using laboratory animal models of respiratory, cardiovascular, autoimmune and metabolic diseases to explore how chronic diseases effect susceptibility to toxicity caused by inhaled toxicants (ozone, particulate matter and silica dust)
With the overall goal to experimentally elucidate cellular, molecular or biochemical targets for interventions to prevent (or treat) adverse effects caused by air pollution